People: Alnylam Pharmaceuticals Inc (ALNY.O)
ALNY.O on Nasdaq
30.25USD
19 Jun 2013
30.25USD
19 Jun 2013
Price Change (% chg)
$0.26 (+0.87%)
$0.26 (+0.87%)
Prev Close
$29.99
$29.99
Open
$29.90
$29.90
Day's High
$30.84
$30.84
Day's Low
$29.70
$29.70
Volume
663,645
663,645
Avg. Vol
404,512
404,512
52-wk High
$31.79
$31.79
52-wk Low
$11.20
$11.20
Mason, Michael
Brief Biography
Mr. Michael P. Mason is Vice President - Finance, Treasurer of Alnylam Pharmaceuticals, Inc. From December 2005 to February 2011, Mr. Mason served as Corporate Controller, and from August 2009 to February 2011, as Senior Director of Finance. From June 2006 to July 2009, Mr. Mason served as Director of Finance. From May 2000 through November 2005, Mr. Mason served in several finance and commercial roles at Praecis Pharmaceuticals Incorporated, a public biotechnology company, most recently as Corporate Controller. Prior to Praecis, Mr. Mason worked in the audit practice at KPMG LLP, a national audit, tax and advisory services firm. Mr. Mason has an MBA and is a certified public accountant.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 305,045 | -- | 101,163 | 488,602 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | 25,295 | 202,711.00 |
| Name | Fiscal Year Total |
|---|---|
John Clarke |
-- |
Barry Greene |
1,640,210 |
John Maraganore |
2,416,010 |
Akshay Vaishnaw |
1,212,190 |
Laurence Reid |
967,914 |
Michael Mason |
488,602 |
As Of 30 Dec 2012

